Circumventing drug resistance: using the substrate envelope hypothesis to develop robust novel HIV1 protease inhibitors

被引:0
|
作者
Nalam, M. N. L. [1 ]
Ali, A. [1 ]
Reddy, K. [1 ]
Altman, M. [2 ]
Chellappan, S. [3 ]
Bandaranayake, R. [1 ]
Anjum, S. G. [1 ]
Rana, T. M. [1 ]
Gilson, M. K. [3 ]
Tidor, B. [2 ]
Schiffer, C. A. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA USA
[2] MIT, Cambridge, MA 02139 USA
[3] Univ Maryland, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S138 / S138
页数:1
相关论文
共 50 条
  • [1] Circumventing drug resistance: using the substrate envelope hypothesis to develop robust novel HIV-1 protease inhibitors
    Nalam, M. N. L.
    Ali, A.
    Reddy, K.
    Altman, M.
    Chellappan, S.
    Bandaranayake, R.
    Anjum, S. G.
    Rana, T. M.
    Gilson, M. K.
    Tidor, B.
    Schiffer, C. A.
    [J]. ANTIVIRAL THERAPY, 2007, 12 (05) : S138 - S138
  • [2] Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance
    Nalam, Madhavi N. L.
    Ali, Akbar
    Altman, Michael D.
    Reddy, G. S. Kiran Kumar
    Chellappan, Sripriya
    Kairys, Visvaldas
    Ozen, Aysegul
    Cao, Hong
    Gilson, Michael K.
    Tidor, Bruce
    Rana, Tariq M.
    Schiffer, Celia A.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (10) : 5368 - 5378
  • [3] Evaluating the 'substrate envelope' hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against resistance
    Nalam, M.
    Ali, A.
    Reddy, K. K.
    Altman, M.
    Chellappan, S.
    Anjum, S.
    Rana, T.
    Gilson, M.
    Tidor, B.
    Schiffer, C.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A69 - A69
  • [4] Using substrate envelope to develop better HIV-1 protease inhibitors
    Kerr, Evelyn
    Bhakta, Meera
    Hunter, Jesi
    Hernandez, John
    Stelluti, Carolyn
    [J]. FASEB JOURNAL, 2020, 34
  • [5] Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis
    Miao Youpan
    Li Aixiu
    Liu Tao
    Wu Kezhu
    Ma Yi
    [J]. ACTA CHIMICA SINICA, 2009, 67 (10) : 1098 - 1102
  • [6] Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease
    Chellappan, Sripriya
    Kairys, Visvaldas
    Fernandes, Miguel X.
    Schiffer, Celia
    Gilson, Michael K.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 68 (02) : 561 - 567
  • [7] New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors
    Nalam, Madhavi N. L.
    Schiffer, Celia A.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2008, 3 (06) : 642 - 646
  • [8] Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance
    Nalam, Madhavi N. L.
    Ali, Akbar
    Reddy, G. S. Kiran Kumar
    Cao, Hong
    Anjum, Saima G.
    Altman, Michael D.
    Yilmaz, Nese Kurt
    Tidor, Bruce
    Rana, Tariq M.
    Schiffer, Celia A.
    [J]. CHEMISTRY & BIOLOGY, 2013, 20 (09): : 1116 - 1124
  • [9] Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis
    Chellappan, Sripriya
    Reddy, G. S. Kiran Kumar
    Ali, Akbar
    Nalam, Madhavi N. L.
    Anjum, Saima Ghafoor
    Cao, Hong
    Kairys, Visvaldas
    Fernandes, Miguel X.
    Altman, Michael D.
    Tidor, Bruce
    Rana, Tariq M.
    Schiffer, Celia A.
    Gilson, Michael K.
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2007, 69 (05) : 298 - 313
  • [10] Substrate envelope based design of potent HIV-1 protease inhibitors resilient to resistance
    Nalam, M. N. L.
    Ali, A.
    Reddy, G. S. K. K.
    Anjum, S. G.
    Rana, T. M.
    Schiffer, C. A.
    [J]. ANTIVIRAL THERAPY, 2010, 15 : A15 - A15